Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 382-391

  Kim, Han Geun ^a   Lee, Seung Yeon ^a   Kim, Na Ra ^a   Lee, Hea Young ^a   Ko, Mi Yeon ^a   Jung, Bong Jun ^a   Kim, Chul Min ^a   Lee, Jung Min ^a   Park, Jong Hwan ^c   Han, Seung Hyun ^b   Chung, Dae Kyun ^a  

^a Kyung Hee University   (South Korea)

^b School of Dentistry   (South Korea)

^c Chosun University   (South Korea)

Author keywords

Inflammation; Lipoteichoic acid; Peptidoglycan; Signal transduction; Tolerance

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOTEICHOIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; COMMENSALISM; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; DOWN REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; INTESTINE; LACTOBACILLUS PLANTARUM; MICROFLORA; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CYTOKINES; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINES; LACTOBACILLUS PLANTARUM; LIPOPOLYSACCHARIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; PEPTIDOGLYCAN; RNA, MESSENGER; SHIGELLA FLEXNERI; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

BACTERIA (MICROORGANISMS); LACTOBACILLUS PLANTARUM; SHIGELLA FLEXNERI;

EID: 78650592605     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.07.011     Document Type: Article

References (70)

1. Andoh A., Fujiyama Y. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J. Gastroenterol. 2006, 12:4452-4460.
2. Ashkenazi S., Levy I., Kazaronovsky V., Samra Z. Growing antimicrobial resistance of Shigella isolates. J. Antimicrob. Chemother. 2003, 51:427-429.
3. Barnich N., Aguirre J.E., Reinecker H.C., Xavier R., Podolsky D.K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J. Cell. Biol. 2005, 170:21-26.
4. Beeson P.B. Tolerance to bacterial pyrogens: I. Factors influencing its development. J. Exp. Med. 1947, 86:29-38.
5. Bera R., Nayak A., Sarkar C., Singh S.K., Ratha J., Bhadra R. Immunological activities of a new nontoxic lipopolysaccharide from Acidiphilium GS18h/ATCC55963, a soil isolate from an Indian copper mine. FEMS Immunol. Med. Microbiol. 2006, 48:107-115.
6. Bhakdi S., Klonisch T., Nuber P., Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 1991, 59:4614-4620.
7. Böhm S.K., Kruis W. Probiotics: do they help to control intestinal inflammation?. Ann. N. Y. Acad. Sci. 2006, 1072:339-350.
8. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., Valvano M.A., Foster S.J., Mak T.W., Nuñez G., Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003, 4:702-707.
9. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168:171-178.
10. Dalpke A.H., Lehner M.D., Hartung T., Heeg K. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 2005, 116:203-212.
11. De Kimpe S.J., Kengatharan M., Thiemermann C., Vane J.R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:10359-10363.
12. DeFranco A.L., Crowley M.T., Finn A., Hambleton J., Weinstein S.L. The role of tyrosine kinases and map kinases in LPS-induced signaling. Prog. Clin. Biol. Res. 1998, 397:119-136.
13. Dobrovolskaia M.A., Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 2002, 4:902-914.
14. Drakes M., Blanchard T., Czinn S. Bacterial probiotic modulation of dendritic cells. Infect. Immun. 2004, 72:3299-3309.
15. Dufner A., Pownall S., Mak T.W. Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-κB activation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:988-993.
16. Dziarski R., Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 2005, 73:5212-5216.
17. Fan H., Cook J.A. Molecular mechanisms of endotoxin tolerance. J. Endotoxin. Res. 2004, 10:71-84.
18. Fischer W., Koch H.U., Haas R. Improved preparation of lipoteichoic acids. Eur. J. Biochem. 1983, 133:523-530.
19. Fritz J.H., Ferrero R.L., Philpott D.J., Girardin S.E. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 2006, 7:1250-1257.
20. Fujihara M., Muroi M., Muroi Y., Ito N., Suzuki T. Mechanism of lipopolysaccharide-triggered JunB activation in a mouse macrophage-like cell line J774. J. Biol. Chem. 1993, 268:14898-14905.
21. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 2003, 100:171-194.
22. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jéhanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zähringer U., Coyle A.J., DiStefano P.S., Bertin J., Sansonetti P.J., Philpott D.J. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003, 300:1584-1587.
23. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003, 278:8869-8872.
24. Girardin S.E., Tournebize R., Mavris M., Page A.L., Li X., Stark G.R., Bertin J., DiStefano P.S., Yaniv M., Sansonetti P.J., Philpott D.J. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2001, 2:736-742.
25. Golenbock D., Aasen A., Solberg R., Ellingsen E., Morath S., Flo T., Schromm A., Hartung T., Thiemermann C., Espevik T., Foster D., Wang J. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 2002, 8:BR149-156.
26. Greisman S.E., Young E.J., Woodward W.E. Mechanisms of endotoxin tolerance. IV: Specificity of the pyrogenic refractory state during continuous intravenous infusions of endotoxin. J. Exp. Med. 1996, 124:983-1000.
27. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001, 13:85-94.
28. Hambleton J., Weinstein S.L., Lem L., DeFranco A.L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2774-2778.
29. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
30. Hedi M., Li J., Cho J.H., Abraham C. Chronic stimulation of NOD2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19440-19445.
31. Hotchikiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
32. Inohara N., Nunez G. NODs: Intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 2003, 3:371-382.
33. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., Nuñez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2: Implications for Crohn's disease. J. Biol. Chem. 2003, 278:5509-5512.
34. Kawata T., Bristol J.R., Rossignol D.P., Rose J.R., Kobayashi S., Yokohama H., Ishibashi A., Christ W.J., Katayama K., Yamatsu I., Kishi Y. E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide. Br. J. Pharmacol. 1999, 127:853-862.
35. Kim H.G., Kim N.R., Gim M.G., Lee J.M., Lee S.Y., Ko M.Y., Kim J.Y., Han S.H., Chung D.K. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-α production in THP-1 cells and endotoxin shock in mice. J. Immunol. 2008, 180:2553-2561.
36. Kim J.H., Seo H., Han S.H., Lin J., Park M.K., Sorensen U.B., Nahm M.H. Monoacyl lipoteichoic Acid from pneumococci stimulates human cells but not mouse cells. Infect. Immun. 2005, 73:834-840.
37. Kim Y.G., Park J.H., Shaw M.H., Franchi L., Inohara N., Núñez G. The cytosolic sensors NOD1 and NOD2 ard critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 2008, 28:246-257.
38. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nuñez G., Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
39. Kohler N.G., Joly A. The involvement of an LPS inducible I kappa B kinase in endotoxin tolerance. Biochem. Biophys. Res. Commun. 1997, 232:602-607.
40. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., Adak G.K., Levine M.M. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Org. 1999, 77:651-666.
41. Kraatz J., Clair L., Rodriguez J.L., West M.A. Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J. Surg. Res. 1999, 83:158-164.
42. Kufer T.A., Fritz J.H., Philpott D.J. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol. 2005, 13:381-388.
43. Kufer T.A., Kremmer E., Banks D.J., Philpott D.J. Role for erbin in bacterial activation of NOD2. Infect. Immun. 2006, 74:3115-3124.
44. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J. Immunol. 2001, 166:5161-5167.
45. Li L., Bin L.H., Li F., Liu Y., Chen D., Zhai Z., Shu H.B. TRIP6 is a RIP2-associated common signaling component of multiple NF-κB activation pathways. J. Cell. Sci. 2005, 118:555-563.
46. Lilly D.M., Stillwell R.H. Probiotics: growth-promoting factors produced by microorganisms. Science 1965, 147:747-748.
47. Lorea Baroja M., Kirjavainen P.V., Hekmat S., Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 2007, 149:470-479.
48. Medvedev A.E., Kopydlowsk K.M., Vogel S.N. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J. Immunol. 2000, 164:5564-5574.
49. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu. Rev. Med. 1987, 38:417-432.
50. Morrison D.C., Jacobs D.M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 1976, 13:813-818.
51. Muroi M., Suzuki T. Role of protein kinase A in LPS-induced activation of NF-κB proteins of a mouse macrophage-like cell line, J774. Cell Signal. 1993, 5:289-298.
52. Nakayama K., Okugawa S., Yanagimoto S., Kitazawa T., Tsukada K., kawada M., Kimura S., Hirai K., Takagaki Y., Ota Y. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 2004, 279:6629-6634.
53. Netea M.G., Kullberg B.J., de Jong D.J., Franke B., Sprong T., Naber T.H., Drenth J.P., Van der Meer J.W. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur. J. Immunol. 2004, 34:2052-2059.
54. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Alkira S. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 2000, 164:3476-3479.
55. Rosenthal R.S., Dziarski R. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 1994, 235:253-285.
56. Sarkar K., Ghosh S., Niyogi S.K., Bhattacharya S.K. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones. Lancet 2003, 361:785.
57. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006, 6:9-20.
58. Suzuki T., Franchi L., Toma C., Ashida H., Ogawa M., Yoshikawa Y., Mimuro H., Inohara N., Sasakawa C., Nuñez G. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 2007, 3:e111.
59. Suzuki T., Nakanishi K., Tsutsui H., Iwai H., Akira S., inohara N., Chamaillard M., Nuñez G., Sasakawa C. A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages. J. Biol. Chem. 2005, 280:14042-14050.
60. Tada H., Aiba S., Shibata K., Ohteki T., Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 2005, 73:7967-7976.
61. Taylor D.N., Echeverria P., Pál T., Sethabutr O., Saiborisuth S., Sricharmom S., Rowe B., Cross J. The role of Shigella spp., enteroinvasive Escherichia coli, and other enteropathogens as causes of childhood dysentery in Thailand. J. Infect. Dis. 1986, 153:1132-1138.
62. Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppée J.Y., Bourdet-Sicard R., Sansonetti P.J., Pédron T. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 2006, 176:1228-1237.
63. Tominaga K., Saito S., Matsuura M., Nakano M. Lipopolysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-kappaB cascades, but not lipopolysaccharide-incorporation steps. Biochim. Biophys. Acta 1999, 1450:130-144.
64. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664.
65. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004, 5:1000-1006.
66. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 1995, 13:437-457.
67. Wang J.H., Doyle M., Manning B.J., Di Wu Q., Blankson S., Redmond H.P. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J. Biol. Chem. 2002, 277:36068-36075.
68. Watanabe T., Kitani A., Murray P.J., Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 2004, 5:800-808.
69. Weinrauch Y., Zychlinsky A. The induction of apoptosis by bacterial pathogens. Annu. Rev. Microbiol. 1999, 53:155-187.
70. Weinstein S.L., Sanghera J.S., Lemke K., DeFranco A.L., Pelech S.L. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 1992, 267:14955-14962.